WA
RYTM icon

WPG Advisers’s Rhythm Pharmaceuticals RYTM Stock Holding History

WPG Advisers’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.44K Sell
58
-2
-3% -$181 ﹤0.01% 899
2026
Q1 		$5.22K Hold
60
– – ﹤0.01% 864
2025
Q4 		$6.42K Buy
60
+3
+5% +$318 ﹤0.01% 832
2025
Q3 		$5.76K Hold
57
– – ﹤0.01% 859
2025
Q2 		$3.6K Buy
+57
New +$3.49K ﹤0.01% 980

Other funds holding RYTM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

WPG Advisers's RYTM Position: Q2 2026 in Review

WPG Advisers reduced its Rhythm Pharmaceuticals (RYTM) stake by 3.3% in Q2 2026, selling an estimated $181 and leaving 58 shares worth $6.44K. The position accounts for ﹤0.01% of the portfolio, ranked #899.

WPG Advisers first reported a position in RYTM in Q2 2025 and has held it in 5 quarters since. 90 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • WPG Advisers held 58 shares of Rhythm Pharmaceuticals worth $6.44K as of Q2 2026.
  • WPG Advisers sold 2 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $181.
  • Rhythm Pharmaceuticals made up ﹤0.01% of WPG Advisers's portfolio in Q2 2026, its #899 holding.
  • WPG Advisers first reported a position in Rhythm Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 90 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.